Healthcare data analytics and real-world evidence platforms
Strategic Profile
The company became a unicorn in 2021, reaching the milestone in 7 years. The Healthcare Map tracks encounters with the healthcare system for over 325 million patients using artificial intelligence and advanced data analytics. This combination of robust clinical insights and enterprise workflows helps life sciences companies, health plans, and patient advocacy groups close care gaps and drive novel therapies to market.
Cyborg Score Rationale
Komodo has raised $514M in funding with a current valuation of $3.3B, demonstrating strong investor confidence. As of May 2026, the company has 756 employees. The company operates in a critical healthcare data analytics market with a proprietary healthcare intelligence asset, though recent funding rounds (last substantial round in November 2022) and competitor activity suggest execution risk in a competitive landscape.
Top Insights
Komodo has paired the industry's most complete view of patient encounters with enterprise cloud technologies to connect individual patient journeys with large-scale health outcomes.
Over 40 companies are building net-new solutions on its platform, including Stanford University, AppliedVR and Turquoise Health.
In January 2025, Komodo partnered with Helix to enhance clinico-genomic datasets for research.
The latest funding round was Series E in November 2022 for $200M, with no announced funding since that date.
Named Competitors
Holmusk — Healthcare data and analytics platform
HealthVerity — Healthcare data exchange and analytics